Einträge von Mithra Pharmaceuticals

Publication of a Transparency Notification Received by Mithra Pharmaceuticals SA/NV

Liège, Belgium 09 January 2017 – Regulated information – In accordance with article 14 of the Law of 2 May 2007 on the disclosure of large shareholdings, Mithra Pharmaceuticals SA/NV publishes the following information: Mithra Pharmaceuticals SA/NV has received a transparency notification dated 29 December 2016, which states that Bart Versluys (Versluys Invest BVBA, Versluys […]

Publication of a Transparency Notification Received by Mithra Pharmaceuticals SA/NV

Liège, Belgium 09 January 2017 – Regulated information – In accordance with article 14 of the Law of 2 May 2007 on the disclosure of large shareholdings, Mithra Pharmaceuticals SA/NV publishes the following information: Mithra Pharmaceuticals SA/NV has received a transparency notification dated 29 December 2016, which states that Bart Versluys (Versluys Invest BVBA, Versluys […]

Publication of a Transparency Notification Received by Mithra Pharmaceuticals SA/NV

Liège, Belgium 09 January 2017 – Regulated information – In accordance with article 14 of the Law of 2 May 2007 on the disclosure of large shareholdings, Mithra Pharmaceuticals SA/NV publishes the following information: Mithra Pharmaceuticals SA/NV has received a transparency notification dated 29 December 2016, which states that Bart Versluys (Versluys Invest BVBA, Versluys […]

Mithra Launches its Product Tibelia on the Global Market

Mithra Pharmaceuticals received 14 Marketing Authorizations (MA) in 12 European countries for its product based on tibolone. Mithra should receive shortly 3 more authorizations for France, Italy and Greece. Tibelia received 24 months shelf-life and should be able to extend this one in 36 months in 2017, what would give the product a unique advantage […]

Mithra Launches its Product Tibelia on the Global Market

Mithra Pharmaceuticals received 14 Marketing Authorizations (MA) in 12 European countries for its product based on tibolone. Mithra should receive shortly 3 more authorizations for France, Italy and Greece. Tibelia received 24 months shelf-life and should be able to extend this one in 36 months in 2017, what would give the product a unique advantage […]

Mithra Launches its Product Tibelia on the Global Market

Mithra Pharmaceuticals received 14 Marketing Authorizations (MA) in 12 European countries for its product based on tibolone. Mithra should receive shortly 3 more authorizations for France, Italy and Greece. Tibelia received 24 months shelf-life and should be able to extend this one in 36 months in 2017, what would give the product a unique advantage […]